It was found that circTNPO3 was highly expressed in resistant ovarian cancer cell lines and tissues, and facilitated paclitaxel chemoresistance via miR-1299/NEK2 axis (Xia et al., 2020). This evidence concerns the gene NEK2 and ovarian carcinoma.